Paulin N Essone
Overview
Explore the profile of Paulin N Essone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Carballo B, Atzeni M, Escadafal C, Vettoretti M, Geis S, Agnandji S, et al.
BMJ Open
. 2025 Feb;
15(2):e086912.
PMID: 39947818
Objectives: To evaluate the effectiveness of 18 different host biomarkers in differentiating bacterial from non-bacterial acute febrile illness (AFI) in resource-limited settings, specifically in Brazil, Malawi and Gabon. Design: Multinational,...
2.
Alabi A, Musangomunei F, Lotola-Mougeni F, Bie-Ondo J, Murphy K, Essone P, et al.
Infection
. 2024 Oct;
52(6):2573-2574.
PMID: 39382777
No abstract available.
3.
Alabi A, Musangomunei F, Lotola-Mougeni F, Bie-Ondo J, Murphy K, Essone P, et al.
Infection
. 2024 Aug;
53(1):285-295.
PMID: 39177882
Purpose: The consequent use of malaria rapid diagnostic tests (RDTs) preceding a treatment decision has improved the global management of malaria. A combination RDT, including an inflammation marker to potentially...
4.
Essone P, Lotola-Mougeni F, Adegbite B, Kokou K, Otogo NNang E, Mabicka E, et al.
Open Forum Infect Dis
. 2024 Aug;
11(8):ofae399.
PMID: 39108932
Background And Objectives: Point-of-care testing using nonsputum samples like serum or plasma proteins can improve tuberculosis (TB) patients access to a definitive diagnosis, especially in resource-constrained and remote areas. Recently,...
5.
Agnandji S, Essone P, Medaglini D, Massinga Loembe M
Lancet Infect Dis
. 2024 Jun;
24(7):671-673.
PMID: 38906583
No abstract available.
6.
Ndjengue Nson L, Ndombi Delpo Dede D, Lotola Mougeni F, Bouassa N, Bennjakhoukh B, Luthi A, et al.
Influenza Other Respir Viruses
. 2024 Jun;
18(6):e13238.
PMID: 38838076
Background: COVID-19 may become a seasonal disease. SARS-CoV-2 active circulation coupled with vaccination efforts has undoubtedly modified the virus dynamic. It is therefore important investigate SARS-CoV-2 dynamic in different groups...
7.
Vianello E, Gonzalez-Dias P, van Veen S, Engele C, Quinten E, P Monath T, et al.
Lancet Microbe
. 2022 May;
3(2):e113-e123.
PMID: 35544042
Background: A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We...
8.
Essone P, Adegbite B, Mbadinga M, Mbouna A, Lotola-Mougeni F, Alabi A, et al.
Infection
. 2022 Feb;
50(4):897-905.
PMID: 35133607
Background: The present study aimed to evaluate the diagnostic utility of creatine kinase-MB (CK-MB), hepcidin (HEPC), phospholipase A2 group IIA (PLa2G2A), and myosin-binding protein C (MYBPC1) for tuberculosis (TB). These...
9.
Mveang Nzoghe A, Padzys G, Maloupazoa Siawaya A, Yattara M, Leboueny M, Avome Houechenou R, et al.
Sci Rep
. 2021 May;
11(1):9672.
PMID: 33958601
In a context where SARS-CoV-2 population-wide testing is implemented, clinical features and antibody response in those infected have never been documented in Africa. Yet, the information provided by analyzing data...
10.
Mveang Nzoghe A, Essone P, Leboueny M, Maloupazoa Siawaya A, Bongho E, Mvoundza Ndjindji O, et al.
Immun Inflamm Dis
. 2020 Dec;
9(1):128-133.
PMID: 33320447
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged throughout the world. Building knowledge around Covid-19 is crucial to devise facts based approaches to respond efficiently against this pandemic....